High-performance Center Single-Cell Technologies LZ-EZT

Through contract research, we work with you to develop practical results in the field of single-cell technologies that can be translated into commercial applications. Proof-of-concept projects serve as the foundation for customized research services and long-term collaborations.

We support single-cell technologies with spin-off potential as well as external startup teams through mentoring, matchmaking, and connections to regional programs such as LZM and Life Science Accelerator. This creates an ecosystem that fosters spin-offs and facilitates the translation of research into market-ready products.

We prepare new and existing intellectual property rights in the field of single-cell technologies specifically for commercialization—including proof-of-concept studies and concise technology descriptions. This gives you access to patented, innovative solutions and suitable licensing models that accelerate the transfer into market-ready applications.

Together with our partners, we are working to standardize processes from cell collection to analysis and contribute this expertise to standards-setting bodies. For example, we support you with questions regarding the IVDR/MDR, liquid biopsy applications, automated processes, and reimbursement, and actively help shape emerging standards.

We offer training courses and workshops on single-cell technologies to enhance our external partners’ understanding and application of these technologies. With training programs tailored to your needs, we help you efficiently integrate the latest technologies into your own research and development processes.

Through training programs and thesis projects in the field of single-cell technologies, we specifically support the development of highly qualified professionals. This fosters a growing network of experts who are integrated into research projects and can eventually be transferred to the industry.

We provide you with access to first-class infrastructure in the field of single-cell technologies - from state-of-the-art laboratory facilities and technical support to consulting services. Tailored infrastructure services enable biotechnology companies to efficiently bring their ideas to life and develop them into market-ready products.

Through targeted science communication, policy dialogues, and public events, we raise awareness of single-cell technologies and position the LZ-EZT as a central hub. At the same time, we strengthen knowledge and technology transfer, support state initiatives in biotechnology and the healthcare industry, and attract future professionals to the field.

• Single-cell-based tumor diagnostics for targeted therapeutic approaches in precision medicine using liquid biopsy
• Use of 3D cell cultures (organoids and tumoroids) to model tumor microenvironments and test therapeutic approaches

• Cell printing and tissue engineering as alternatives to animal testing and for the development of new cell therapies

• Patented on-demand dispensing of single cells in picoliter droplets for additive manufacturing
  

• Enzyme-free tissue dissociation using technologies such as TissueGrinder and µTissueGrinder
• Automated sample processing platforms for clinical research and therapy
• Physical and genetic single-cell phenotyping for tumor diagnostics and drug development
• Sorting of 3D cell cultures for standardized assays

• Interfaces with the biobank for quality management and sample traceability

• Optimized process chains from the operating room through pathology to the biobank to ensure the highest tissue quality

• Implementation of process controls for quality assurance of tissue and samples